Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 90 | 網膜色素変性症 | 1 |
90. 網膜色素変性症
臨床試験数 : 130 / 薬物数 : 180 - (DrugBank : 41) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 109
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04763369 (ClinicalTrials.gov) | February 2021 | 6/2/2021 | Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP) | Investigation of Therapeutic Efficacy and Safety of Umbilical Cord Derived Mesenchymal Stem Cells (UMSCs) for the Management of Retinitis Pigmentosa (RP) | Retinitis Pigmentosa (RP) | Biological: Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa;Biological: Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa | Jinnah Burn and Reconstructive Surgery Centre, Lahore | The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township Lahore.;Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore. | Recruiting | 18 Years | 70 Years | All | 50 | Phase 2 | Pakistan |